Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment
Open Access
- 20 April 2016
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (7) , 965-972
Abstract
No abstract availableKeywords
Funding Information
- Liz Dawn charity (8Y07)
- Leeds Cancer Research UK
This publication has 22 references indexed in Scilit:
- Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant TherapyJNCI: Journal of the National Cancer Institute, 2013
- Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapyEuropean Journal of Cancer, 2012
- Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIALRadiology, 2012
- Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro StudyJournal of Clinical Oncology, 2010
- Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancerBritish Journal of Cancer, 2008
- MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapyCancer, 2007
- Neoadjuvant chemotherapy for operable breast cancerBritish Journal of Surgery, 2007
- Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapyHistopathology, 2006
- Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast CancerAmerican Journal of Roentgenology, 2005
- In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot studyAnnals of Oncology, 2005